消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

中国胃肠间质瘤内镜下诊治专家共识意见（2020·北京）

2020-11-25 中华医学会内镜学分会 中华胃肠内镜电子杂志.2020.7(4):176-185.

胃肠间质瘤

但国内关于GIST 内镜下诊断、治疗及随访等问题均尚无统一的专家共识，因此制定一项全面的、以证据为基础的《中国胃肠间质瘤内镜下诊治共识意见》显得十分必要。为此，由中华医学会消化内镜分会与中国医师协会内

中文标题：

中国胃肠间质瘤内镜下诊治专家共识意见（2020·北京）

发布机构：

中华医学会内镜学分会

发布日期：

2020-11-25

简要介绍：

但国内关于GIST 内镜下诊断、治疗及随访等问题均尚无统一的专家共识，因此制定一项全面的、以证据为基础的《中国胃肠间质瘤内镜下诊治共识意见》显得十分必要。为此，由中华医学会消化内镜分会与中国医师协会内镜医师分会牵头，组织国内相关领域专家参考相关的最新研究进展，通过集体讨论与投票等方式，共同制定本共识意见。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=中国胃肠间质瘤内镜下诊治专家共识意见_2020_北京_柴宁莉.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0fe0f1c002029815, title=中国胃肠间质瘤内镜下诊治专家共识意见（2020·北京）, enTitle=, guiderFrom=中华胃肠内镜电子杂志.2020.7(4):176-185., authorId=0, author=, summary=但国内关于GIST 内镜下诊断、治疗及随访等问题均尚无统一的专家共识，因此制定一项全面的、以证据为基础的《中国胃肠间质瘤内镜下诊治共识意见》显得十分必要。为此，由中华医学会消化内镜分会与中国医师协会内, cover=https://img.medsci.cn/20201227/1609071657839_2020535.jpg, journalId=0, articlesId=null, associationId=381, associationName=中华医学会内镜学分会, associationIntro=null, copyright=0, guiderPublishedTime=Wed Nov 25 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>但国内关于GIST 内镜下诊断、治疗及随访等问题均尚无统一的专家共识，因此制定一项全面的、以证据为基础的《中国胃肠间质瘤内镜下诊治共识意见》显得十分必要。为此，由中华医学会消化内镜分会与中国医师协会内镜医师分会牵头，组织国内相关领域专家参考相关的最新研究进展，通过集体讨论与投票等方式，共同制定本共识意见。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1248, tagName=胃肠间质瘤)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1248, guiderKeyword=胃肠间质瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5111, appHits=296, showAppHits=0, pcHits=961, showPcHits=4815, likes=4, shares=28, comments=14, approvalStatus=1, publishedTime=Sun Dec 27 22:03:53 CST 2020, publishedTimeString=2020-11-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Dec 27 20:21:03 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 17:23:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国胃肠间质瘤内镜下诊治专家共识意见_2020_北京_柴宁莉.pdf)])
中国胃肠间质瘤内镜下诊治专家共识意见_2020_北京_柴宁莉.pdf
下载请点击：
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1198076, encodeId=90fa11980e6a5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ab26527797, createdName=ms3000001051299218, createdTime=Mon Feb 28 16:50:50 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193963, encodeId=5156119396397, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/221a72297eec4d9eab6800ef70ceb422/54348a02c6134980b878a226b1af9f27.jpg, createdBy=2d005542057, createdName=秦文举, createdTime=Wed Feb 16 11:22:47 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180515, encodeId=2f03118051504, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a85549889, createdName=ms2000000182667314, createdTime=Tue Jan 04 18:49:47 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178977, encodeId=571511e89771a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e61c5483472, createdName=ms4000000609908410, createdTime=Thu Dec 30 21:13:52 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085486, encodeId=075a108548616, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2cd5399260, createdName=ms3000000121177566, createdTime=Wed Dec 29 16:15:23 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-02-28 ms3000001051299218

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1198076, encodeId=90fa11980e6a5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ab26527797, createdName=ms3000001051299218, createdTime=Mon Feb 28 16:50:50 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193963, encodeId=5156119396397, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/221a72297eec4d9eab6800ef70ceb422/54348a02c6134980b878a226b1af9f27.jpg, createdBy=2d005542057, createdName=秦文举, createdTime=Wed Feb 16 11:22:47 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180515, encodeId=2f03118051504, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a85549889, createdName=ms2000000182667314, createdTime=Tue Jan 04 18:49:47 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178977, encodeId=571511e89771a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e61c5483472, createdName=ms4000000609908410, createdTime=Thu Dec 30 21:13:52 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085486, encodeId=075a108548616, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2cd5399260, createdName=ms3000000121177566, createdTime=Wed Dec 29 16:15:23 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-02-16 秦文举

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1198076, encodeId=90fa11980e6a5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ab26527797, createdName=ms3000001051299218, createdTime=Mon Feb 28 16:50:50 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193963, encodeId=5156119396397, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/221a72297eec4d9eab6800ef70ceb422/54348a02c6134980b878a226b1af9f27.jpg, createdBy=2d005542057, createdName=秦文举, createdTime=Wed Feb 16 11:22:47 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180515, encodeId=2f03118051504, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a85549889, createdName=ms2000000182667314, createdTime=Tue Jan 04 18:49:47 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178977, encodeId=571511e89771a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e61c5483472, createdName=ms4000000609908410, createdTime=Thu Dec 30 21:13:52 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085486, encodeId=075a108548616, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2cd5399260, createdName=ms3000000121177566, createdTime=Wed Dec 29 16:15:23 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-01-04 ms2000000182667314

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1198076, encodeId=90fa11980e6a5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ab26527797, createdName=ms3000001051299218, createdTime=Mon Feb 28 16:50:50 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193963, encodeId=5156119396397, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/221a72297eec4d9eab6800ef70ceb422/54348a02c6134980b878a226b1af9f27.jpg, createdBy=2d005542057, createdName=秦文举, createdTime=Wed Feb 16 11:22:47 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180515, encodeId=2f03118051504, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a85549889, createdName=ms2000000182667314, createdTime=Tue Jan 04 18:49:47 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178977, encodeId=571511e89771a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e61c5483472, createdName=ms4000000609908410, createdTime=Thu Dec 30 21:13:52 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085486, encodeId=075a108548616, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2cd5399260, createdName=ms3000000121177566, createdTime=Wed Dec 29 16:15:23 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-30 ms4000000609908410

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1198076, encodeId=90fa11980e6a5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ab26527797, createdName=ms3000001051299218, createdTime=Mon Feb 28 16:50:50 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193963, encodeId=5156119396397, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/221a72297eec4d9eab6800ef70ceb422/54348a02c6134980b878a226b1af9f27.jpg, createdBy=2d005542057, createdName=秦文举, createdTime=Wed Feb 16 11:22:47 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180515, encodeId=2f03118051504, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a85549889, createdName=ms2000000182667314, createdTime=Tue Jan 04 18:49:47 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178977, encodeId=571511e89771a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e61c5483472, createdName=ms4000000609908410, createdTime=Thu Dec 30 21:13:52 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085486, encodeId=075a108548616, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2cd5399260, createdName=ms3000000121177566, createdTime=Wed Dec 29 16:15:23 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-29 ms3000000121177566

    学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

胃肠间质瘤全程化管理中国专家共识（2020 版）

中华医学会外科学分会胃肠外科学组 · 2020-10-15

酪氨酸激酶抑制剂治疗胃肠间质瘤不良反应及处理共识

中国医师协会外科医师分会 · 2019-09-30

中国胃肠间质瘤诊断治疗共识（2017 年版）

CSCO胃肠间质瘤专家委员会 · 2018-02-20

胃肠间质瘤多学科综合治疗协作组诊疗模式专家共识

中国研究型医院学会(CRHA,Chinese Research Hospital Association) · 2017-01-30

中国胃肠间质瘤诊断治疗共识(2013年版)

CSCO胃肠间质瘤专家委员会 · 2013-11-01

拓展阅读

中国胃肠间质瘤诊断治疗共识(2013年版)

CSCO胃肠间质瘤专家委员会 · 2013-11-01

胃肠间质瘤多学科综合治疗协作组诊疗模式专家共识

中国研究型医院学会(CRHA,Chinese Research Hospital Association) · 2017-01-30

中国胃肠间质瘤诊断治疗共识（2017 年版）

CSCO胃肠间质瘤专家委员会 · 2018-02-20

酪氨酸激酶抑制剂治疗胃肠间质瘤不良反应及处理共识

中国医师协会外科医师分会 · 2019-09-30

胃肠间质瘤全程化管理中国专家共识（2020 版）

中华医学会外科学分会胃肠外科学组 · 2020-10-15

CSCO指南：胃肠间质瘤（2020）

CSCO胃肠间质瘤专家委员会 · 2020-07-01